enteric pathogenic bacteria

基本解释

AIM : To evaluate the clinical and bacterial effectiveness and safety of levofloxacin (LVLX) made in China in the treatment of enteric pathogenic bacteria.
目的：为观察国产左氟沙星（LVLX）治疗肠道细菌感染的疗效、细菌学效果和安全性。
Objective To monitor the distribution and resistance of enteric pathogenic bacteria in Beijing area to offer the data for guiding epidemiologic study and clinical treatment.
目的监测北京地区肠道致病菌的组成及耐药状况，为本地区的流行病学研究及临床合理用药提供依据。
Results The amplicons of Yersinia pestis DNA were the same with the anticipative products. Only internal control amplicon was gotten while amplifying other enteric pathogenic bacteria DNA.
结果鼠疫菌DNA模板可扩增出预期产物，而其他菌株只能扩增出内部对照模板的片段。